Xilio Therapeutics implements 1-for-14 reverse stock split
Xilio Therapeutics, Inc. (NASDAQ: XLO) will implement a 1-for-14 reverse stock split of its common stock effective at 5:00 p.m ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
